尽管该公司的股票评级为“买入”，但 Artivion 内部人士仍出售了大量股票。 Artivion insiders sold significant shares despite the company’s stock having a "Buy" rating.

Artivion, Inc. (NYSE: AORT) 本月有两家内幕销售公司:SVP Jean F. Holloway以425 452.20美元出售18 020股股票,将她的股份减少了8.37%,John E. Davis主任以356 511美元出售15 100股,减少了6.74%。 Artivion, Inc. (NYSE: AORT) saw two insider sales this month: SVP Jean F. Holloway sold 18,020 shares for $425,452.20, reducing her holdings by 8.37%, and director John E. Davis sold 15,100 shares for $356,511, a 6.74% reduction. 医疗器械公司Artivion最近报告净利为负, 股权回报为正, 市值为9.86.28亿美元. Artivion, a medical device company, recently reported a negative net margin and positive return on equity, with a market cap of $986.28 million. 公司股票的“Buy”评级为31.40美元,目标价格为31.40美元。 The company's stock has a "Buy" rating with a target price of $31.40.